Suramin's Effect on Endothelial Cell Growth and Angiogenesis
Author Information
Author(s): R. Danesi, S. Del Bianchi, P. Soldani, A. Campagni, R.V. La Rocca, C.E. Myers, A. Paparelli, M. Del Tacca
Primary Institution: Scuola Superiore di Studi Universitari e di Perfezionamento S. Anna
Hypothesis
Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis.
Conclusion
Suramin is a more potent inhibitor of angiogenesis than the combination of heparin and hydrocortisone.
Supporting Evidence
- Suramin inhibited the 4-fold increase in [3H]-thymidine uptake in endothelial cells stimulated by bFGF.
- bFGF antisense oligomer reduced [3H]-thymidine incorporation by 76%.
- Suramin-treated CAMs showed a significantly larger area with reduced vascularity compared to controls.
Takeaway
Suramin can stop certain cells from growing and forming new blood vessels, which might help in treating cancer.
Methodology
The study evaluated the effects of suramin on endothelial cell proliferation and angiogenesis using chick embryos and various assays.
Limitations
The study did not explore the long-term effects of suramin on vascularization.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website